EYEGM Trademark

Trademark Overview

On Friday, April 5, 2024, a trademark application was filed for EYEGM with the United States Patent and Trademark Office. The USPTO has given the EYEGM trademark a serial number of 98486023. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 5, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EYEGM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for genetic research and gene therapy; providing a database of information relating to diseases and genetic information
eyegm

General Information

Serial Number98486023
Word MarkEYEGM
Filing DateFriday, April 5, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, April 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for genetic research and gene therapy; providing a database of information relating to diseases and genetic information

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 5, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, April 5, 2024NEW APPLICATION ENTERED
Wednesday, September 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

eyegm information genetic providing therapy database service diseases relating gene research